Literature DB >> 11707305

Vaccines against cysticercosis and hydatidosis.

M W Lightowlers1, C G Gauci.   

Abstract

The recombinant vaccines that have been developed against cysticercosis and hydatidosis in sheep and cattle are remarkable for their effectiveness and are prominent as examples of the very few non-living vaccines against parasitic diseases. Their development has been through practical application of molecular parasitology, utilising immunochemical techniques in antigen identification and recombinant DNA methods in antigen production. This brief overview discusses the contribution of molecular techniques to the successful development of recombinant vaccines against Taenia ovis, Taenia saginata and Echinococcus granulosus as well as the immunological and genomic studies that have arisen from their development.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11707305     DOI： 10.1016/s0304-4017(01)00559-3

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN： 0304-4017            Impact factor:   2.738


  9 in total

1.  Molecular and functional characterization of a Taenia adhesion gene family (TAF) encoding potential protective antigens of Taenia saginata oncospheres.

Authors:  Luis Miguel Gonzalez; Pedro Bonay; Laura Benitez; Elizabeth Ferrer; Leslie J S Harrison; R Michael E Parkhouse; Teresa Garate
Journal:  Parasitol Res       Date:  2006-10-18       Impact factor: 2.289

2.  DNA immunization with Na+-K+ ATPase (Sseat-6) induces protective immunity to larval Strongyloides stercoralis in mice.

Authors:  Laura A Kerepesi; Paul B Keiser; Thomas J Nolan; Gerhard A Schad; David Abraham; Thomas B Nutman
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

3.  Induction of protection against porcine cysticercosis by vaccination with recombinant oncosphere antigens.

Authors:  Ana Flisser; Charles G Gauci; André Zoli; Joel Martinez-Ocaña; Adriana Garza-Rodriguez; Jose Luis Dominguez-Alpizar; Pablo Maravilla; Rossana Rodriguez-Canul; Guillermina Avila; Laura Aguilar-Vega; Craig Kyngdon; Stanny Geerts; Marshall W Lightowlers
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

Review 4.  Taenia solium cysticercosis.

Authors:  Héctor H García; Armando E Gonzalez; Carlton A W Evans; Robert H Gilman
Journal:  Lancet       Date:  2003-08-16       Impact factor: 79.321

5.  Cystic echinococcosis in the sheep: causes of its persistence in Sardinia.

Authors:  A Scala; R Mazzette
Journal:  Vet Res Commun       Date:  2009-09       Impact factor: 2.459

6.  Molecular cloning of a vaccine antigen against infection with the larval stage of Echinococcus multilocularis.

Authors:  Charles Gauci; Michael Merli; Volker Muller; Conan Chow; Kinpei Yagi; Ute Mackenstedt; Marshall W Lightowlers
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

7.  Construction and Identification of a Recombinant Plasmid Encoding Echinococcus granulosus Oncosphere Antigen (EG95).

Authors:  Nahideh Mazaheri; Abdolhossein Dalimi; Majid Pirestani; Farnoosh Jameie; Mehdi Mohebali; Mohamad Bagher Rokni
Journal:  Iran J Parasitol       Date:  2017 Oct-Dec       Impact factor: 1.012

8.  Modulation of the Immune Response to DNA Vaccine Encoding Gene of 8-kDa Subunit of Echinococcus granulosus Antigen B Using Murine Interleukin-12 Plasmid in BALB/c Mice.

Authors:  Hakim Azizi; Bahram Kazemi; Mojgan Bandehpour; Mehdi Mohebali; Ali Khamesipour; Mojgan Aryaeipour; Hajar Yaghoobi; Mohammad Bagher Rokni
Journal:  Iran J Parasitol       Date:  2016 Oct-Dec       Impact factor: 1.012

9.  An oral recombinant vaccine in dogs against Echinococcus granulosus, the causative agent of human hydatid disease: a pilot study.

Authors:  Anne-Francoise Petavy; Carlos Hormaeche; Samia Lahmar; Hammou Ouhelli; Alejandro Chabalgoity; Thierry Marchal; Samira Azzouz; Fernanda Schreiber; Gabriela Alvite; Marie-Elisabeth Sarciron; Duncan Maskell; Adriana Esteves; Georges Bosquet
Journal:  PLoS Negl Trop Dis       Date:  2008-01-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.